Asclepii Unveils Poseidon Wound Care Solution Backed by Science

Author: Owen Jenkins Updated: 08-29-2025 12:01 PM

Exciting Launch of Poseidon™ by Asclepii

Cleveland-based healthcare startup Asclepii proudly announces the launch of Poseidon™, an innovative FDA-cleared nanosilver hydrogel aimed at revolutionizing wound care. This advanced product is engineered with a focus on accelerating healing while providing remarkable safety for patients.

Overview of Poseidon™

Poseidon™ stands out as the market's leading nanosilver hydrogel, offering a unique formulation that supports multi-dimensional healing processes. With one of the lowest silver concentrations available, this groundbreaking technology protects healthy tissue while providing effective healing for both acute and chronic wounds. Asclepii's new product is designed to deliver enhanced precision and scalability, making it adept at managing various wound conditions.

A Personal Journey to Innovation

Franco Kraiselburd, Founder and CEO of Asclepii, shared the significance of this launch, saying, "Since I began my journey into regenerative medicine at twelve years old, unveiling Poseidon™ in Cleveland is a deeply fulfilling milestone. This product signifies a leap forward in regenerative medicine, merging cutting-edge nanotechnology with patient safety and accessibility."

Clinical Benefits

Clinical evaluations of Poseidon™ reveal impressive results. Participants reported that 96% showed no clinical signs of infection within just eight days of using the hydrogel, significantly outperforming other comparable treatments. This reflects Poseidon™'s role in minimizing infection risks while effectively promoting wound closure.

Key Features and Advantages

The Poseidon™ hydrogel is designed with several standout features:

Advanced Nanotechnology: The formulation includes optimally sized silver nanoparticles at a concentration of just 1ppm, which offers antimicrobial effectiveness similar to solutions containing 30-100ppm, maximizing both safety and efficiency.
Innovative Hydrogel Barrier: This hydrogel forms a moisturizing layer, buffering wounds while absorbing exudates and controlling odors. Its ability to dry invisibly ensures comfortable application without the need for traditional bandages.
Dermatologically Safe: The four-ingredient formula is designed to be hypoallergenic, reducing the risk of irritation often associated with antibiotics like neomycin and bacitracin.
Environmentally Conscious: Poseidon™ is non-toxic and free from any harmful compounds, ensuring it's safe for both users and the environment.

Looking Ahead

Asclepii's Poseidon™ not only offers a remarkable solution for effective healing but also emphasizes the company's commitment to patient care and technological advancement. Interested parties can discover more about Poseidon™ and its benefits by visiting Asclepii’s official website or contacting them directly.

Frequently Asked Questions

What is Poseidon™?

Poseidon™ is an FDA-cleared nanosilver hydrogel developed by Asclepii to expedite wound healing while maintaining patient safety.

How does Poseidon™ compare to other wound care products?

Poseidon™ uses cutting-edge nanotechnology with a lower concentration of silver while delivering strong antimicrobial properties, making it safer and more effective.

What are the clinical results associated with Poseidon™?

Clinical studies show that 96% of patients experienced no infection symptoms after just eight days of treatment with Poseidon™.

Is Poseidon™ safe for all types of wounds?

Yes, Poseidon™ is designed for both acute and chronic wounds, ensuring broad applicability in various wound care scenarios.

Where can I find more information about Asclepii?

For more details, visit the official Asclepii website or contact their customer service directly.

About The Author

Hi there I'm 38-year-old author and financial consultant Owen Jenkins. Having worked in the financial sector for more than ten years, I am well-versed in the subtleties and complexity that mold our financial environment. Following a degree in finance, I worked in a number of financial institutions honing my abilities in market analysis, financial planning, and investment strategies.

My love is teaching others about investing and personal finance. My goal in writing many books and articles has been to demystify financial ideas and give readers the information they need to make wise financial decisions. I write with a direct, useful style that emphasizes doable suggestions for daily living.

Along with writing, I lead webinars and seminars where I impart knowledge on how to successfully negotiate the financial world. I also write for financial journals and show up as a guest expert on financial news programs a lot. Whether they are new to investing or want to improve their approach, my mission is to enable people to take charge of their financial futures.

Beyond work, I like to hike, play the guitar, and spend time with my family. I think that balance is crucial and want to encourage people to strike a balance between their financial aspirations and their hobbies. I want to help people succeed and achieve financial security through my work, so having a good influence.

Contact Owen Jenkins privately here. Or send an email with ATTN: Owen Jenkins as the subject to contact@investorshangout.com.

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.